Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

Ahmad Masri, Mark V. Sherrid, Theodore P. Abraham, Lubna Choudhury, Pablo García‐Pavía, Christopher M. Kramer, Roberto Barriales‐Villa, Anjali Owens, Florian Rader, Sherif F. Nagueh, Iacopo Olivotto, Sara Saberi, Albree Tower‐Rader, Timothy C. Wong, Caroline Coats, Hugh Watkins, Michael A. Fifer, Scott D. Solomon, Stephen B. Heitner, Daniel Jacoby, Stuart Kupfer, Fady I. Malik, Lisa Meng, Regina Sohn, Amy Wohltman, Martin S. Maron